Chilean Cobalt Raises $1.5M from Madesal, Advances NeoRe Acquisition
COBA has more than doubled off its 52-week low of $0.19.
Summary
Chilean Cobalt raised $1.5 million from strategic investor Madesal SpA via a private placement of 750,000 shares at $2.00, while advancing its NeoRe rare earth acquisition with a proposed 6 million share consideration.
Key Events · Financing and Capital Events · COBA
-
Strategic $1.5M Placement
Madesal SpA purchased 750,000 shares at $2.00 per share for $1.5 million in gross proceeds, deepening its existing strategic stake.
-
NeoRe Acquisition Consideration
The proposed acquisition of 100% of NeoRe contemplates 6,000,000 Chilean Cobalt common shares as consideration, subject to a definitive agreement.
-
Phase 2 Earn-In Completed
Chilean Cobalt earned a second 1% NSR royalty (total 2%) on the NeoRe Rare Earth Project, with the royalties to be extinguished if the acquisition closes.
-
Use of Proceeds
Proceeds will fund district consolidation, exploration, early ESG work, and general corporate purposes.
Analysis · COBA · Energy & Transportation
Chilean Cobalt sold 750,000 shares at $2.00 to Madesal SpA, the controlling shareholder of NeoRe, raising $1.5 million. The placement deepens alignment with its strategic partner as the company advances toward acquiring 100% of NeoRe for 6 million shares. The capital supports district consolidation, exploration, and ESG work, but the issuance adds modest dilution to existing holders.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 29.9% of the 1988 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.12%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, COBA was trading at $2.41 on OTC in the Energy & Transportation sector, with a market capitalization of approximately $139.7M. The 52-week trading range was $0.19 to $4.30. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.